Nasonex gains FDA nod for sale over-the-counter
Sale of Perrigo's Nasonex 24HR Allergy, or mometasone furoate
monohydrate, for over-the-counter use has been approved by the FDA. The
intranasal corticosteroid nasal spray is designed as a treatment for and to
prevent allergy and hay fever symptoms and is expected to become available
later this year as an OTC product.
Full Story: Healio
(free registration) (3/21)
No comments:
Post a Comment